When: RSI bullish divergence

Then: Re-engagement eligible with two-of-four confirmations

When: Forward EPS stabilization or rise post-quarterly

Then: Re-engagement eligible with two-of-four confirmations

TRIM 60-75% immediately at current market; stop residual at 97 with hard close-below exit trigger; no new capital into name until ROE >13%, FCF >$2B/quarter, 50 SMA reclaimed 200 SMA, price >110 with volume confirmation

• HOLD position is dangerous given price below all major moving averages, expanding negative MACD histogram, weak/falling RSI, imminent death cross, FCF collapsed 65% sequentially to $920M from $2.63B, SG&A spiked $1.8B, negative tangible book, ROE below WACC
• 104-106 entry zone assumption is flawed—trim into current strength at 102.61 rather than waiting for relief rally to resistance cluster at 10 EMA/50 SMA/200 SMA where August breakdown occurred
• Stop loss at 100 is too tight—only 2.61 below current price or ~1x ATR; in elevated volatility regime with 10Y near 5%, no Fed cuts priced at 95%, geopolitical uncertainty, stop needs to be at minimum 97.50 below lower Bollinger Band at 97.63
• 25-40% trim is insufficient given thesis that ROE below WACC, negative tangible book, collapsing FCF, unprecedented $20B integration debt, forward EPS likely revised down 60-70%
• Dividend at 2.47% is a trap, not compensation—payout ratio 78% of TTM net income, FCF not covering dividends at current annualized rate, being funded by debt or balance sheet drawdown
• Dividend at risk due to 63% debt-to-equity leverage, $20B new debt absorption, flowing-through integration costs, and potential Exact Sciences synergy disappointment—board may cut to 'preserve capacity for integration'
• Re-entry prerequisites: ROE back above 13%, FCF recovered to normalized run rate above $2B/quarter, 50 SMA reclaimed 200 SMA, price back above 110 with volume confirmation
• Conservative mandate prioritizes preserving 40-60% of position from additional 12-15% drawdown exposure if integration disappoints; if stock rallies to 115 instead, disciplined re-entry is acceptable

→ vs neutral: HOLD position is not defensive but passive—failed bounce at 10 EMA or 50 SMA creates overhead supply; RSI approaching oversold (28) does not guarantee bounce in persistent downtrends with deteriorating fundamentals; lower Bollinger Band at 97.63 is mean-reversion statistic not structural support; 'mild higher low' from 101.95 to 102.61 is four sessions of noise inside four-week downtrend

→ vs aggressive: Entry price of 104-106 assumes relief rally that broken technical structure and imminent death cross contradict—algorithmic systems triggering death cross sells won't be buyers at resistance zone; trim should occur at current market 102.61, not phantom rally zone

→ vs aggressive: Stop loss at 100 (only 2.61 below current price, ~1x ATR) is far too tight given elevated macro risk—will get clipped by single bad session gap-down or algorithmic flush; stop should be at minimum 97.50 beneath lower Bollinger Band with buffer

→ vs aggressive: 25-40% trim is insufficient given thesis severity—leaving 60-75% of position in when ROE below WACC, tangible book negative, FCF collapsing, $20B integration debt, EPS revisions down 60-70% contradicts the bearish diagnosis

Trim 40-50% of position in tranches (1/3 immediately at market, 1/3 on any move toward 104, hold final 1/3 for 106); set closing-basis stop at 98 with tightening to 99 if price reclaims 105 with above-average volume; evaluate re-investment against alternatives in the same macro regime rather than parking cash.

• Trim 40-50% of position in tranches: take a third off immediately at market, another third on any move back toward 104, hold final third for 106 if it prints
• Set a closing-basis stop at 98 on the residual core position, representing a hard break below the lower Bollinger Band at 97.63 with a small buffer
• Tighten stop to 99 only if price reclaims 105 on a closing basis with above-average volume, as that would signal meaningful change in technical character
• FCF of 7.21 billion TTM comfortably covers 4.2 billion in dividends (coverage ratio 1.72x), contradicting conservative analyst's dividend cut thesis
• Macro environment supports dividend-paying low beta compounders: 10-year yields near 5%, no Fed cuts priced at 95%, US recession probability at 8%, ABT beta of 0.586
• Re-entry framework should consider portfolio context and alternatives in the same macro regime, not be made in isolation
• Death cross is a tactical signal, not structural damage to the dividend franchise
• Fundamentals are temporarily depressed by known integration costs flowing through operating expenses, not destroying underlying cash generation
• Abbott has maintained dividend policy through prior integration cycles including the messier Alere acquisition; 50-year track record is not worthless
• Conservative analyst's re-entry conditions (ROE above 13%, FCF above 2B/quarter, 50 SMA reclaiming 200 SMA, price above 110) could take 12-18 months minimum and may miss the re-rating

→ vs aggressive: Waiting for relief rally to 104-106 is flawed because all overhead moving averages (10 EMA at 104.05, 200 SMA at 104.22, 50 SMA at 105.98) are stacked in a 1.93 dollar zone that August breakdown occurred through—this is a magnet for sellers, not a launchpad

→ vs aggressive: Stop at 100 (roughly 1x ATR of 2.52) is too tight for a risk-off regime with 10-year at 5 percent and 95 percent of market pricing no Fed cuts in 2026; single gap down through 100 would stop out at exactly the level where everyone else has stops clustered

→ vs aggressive: Failed to acknowledge whether the September 18th volume spike of 27 million shares (3-4x normal) was capitulation or distribution—the single most important data point in the technical report

→ vs conservative: Dividend cut thesis is wrong: Abbott paid 4.2 billion in dividends TTM against 7.21 billion in FCF (1.72x coverage), and even if Q1 2026 FCF of 920 million repeats for four quarters, annual FCF still covers annual dividends

→ vs conservative: Board dividend cut claim is speculation with zero evidence in filings or analyst commentary; Abbott has explicitly maintained dividend policy through prior integration cycles including the Alere acquisition

→ vs conservative: Re-entry framework of ROE above 13 percent, FCF above 2B per quarter, 50 SMA reclaiming 200 SMA, price above 110 is actually an exit strategy disguised as patience—those conditions simultaneously could take 12-18 months minimum, during which the stock could already be at 115-120